Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

Jacques W.M. Lenders, Quan‐Yang Duh, Anne‐Paule Gimenez‐Roqueplo et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 2.8K citations · Full text

Medicine, Endocrinology, Oncology +17

Biochemical Diagnosis of Pheochromocytoma

Jacques W.M. Lenders, Karel Pacák, McClellan M. Walther et al. · JAMA · 2002 · 1.1K citations

Medicine, Endocrinology, Oncology +16

Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine

David S. Goldstein, Patricia Sullivan, György Csákó et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 236 citations · Full text

Medicine, Endocrinology, Oncology +14

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites

Graeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch et al. · Clinical Chemistry · 2018 · 176 citations · Full text

Medicine, Oncology, Cancer Screening +13

Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction

Vanessa M. Ferreira, Mafalda Marcelino, Stefan K. Piechnik et al. · Journal of the American College of Cardiology · 2016 · 152 citations · Full text

Medicine, Cardiology, Radiology +16